These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10858601)

  • 1. Depsides as non-redox inhibitors of leukotriene B(4) biosynthesis and HaCaT cell growth, 2. Novel analogues of obtusatic acid.
    Kumar KC S; Müller K
    Eur J Med Chem; 2000 Apr; 35(4):405-11. PubMed ID: 10858601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 10-Phenylbutyryl-substituted anthracenones as inhibitors of keratinocyte growth and LTB(4) biosynthesis.
    Müller K; Breu K; Reindl H
    Eur J Med Chem; 2001 Feb; 36(2):179-84. PubMed ID: 11311748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
    Müller K; Reindl H; Breu K
    J Med Chem; 2001 Mar; 44(5):814-21. PubMed ID: 11262091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsoriatic anthrones with modulated redox properties. 3. 10-thio-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of keratinocyte growth, 5-lipoxygenase, and the formation of 12(S)-HETE in mouse epidermis.
    Müller K; Huang HS; Wiegrebe W
    J Med Chem; 1996 Aug; 39(16):3132-8. PubMed ID: 8759634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lichen metabolites. 1. Inhibitory action against leukotriene B4 biosynthesis by a non-redox mechanism.
    Kumar KC; Müller K
    J Nat Prod; 1999 Jun; 62(6):817-20. PubMed ID: 10395494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
    Müller K; Leukel P; Ziereis K; Gawlik I
    J Med Chem; 1994 May; 37(11):1660-9. PubMed ID: 8201600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of neutrophil leukotriene B4 production by a novel synthetic N-3 polyunsaturated fatty acid analogue, beta-oxa 21:3n-3.
    Robinson BS; Rathjen DA; Trout NA; Easton CJ; Ferrante A
    J Immunol; 2003 Nov; 171(9):4773-9. PubMed ID: 14568954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4.
    Steel HC; Tintinger GR; Theron AJ; Anderson R
    Clin Exp Immunol; 2007 Oct; 150(1):144-50. PubMed ID: 17683509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecules that antagonize leukotriene B4 binding to neutrophils.
    Lin AH; Morris J; Wishka DG; Gorman RR
    Ann N Y Acad Sci; 1988; 524():196-200. PubMed ID: 2837955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3-alkyl- and 3-aryl-(7-oxo-7H-furo[3, 2-g]chromen-5-yl)alkanoic acids as inhibitors of leukotriene B4 biosynthesis.
    Körner P
    Arch Pharm (Weinheim); 2003 Aug; 336(6-7):273-84. PubMed ID: 12953215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 10-alpha-Aminoacyl-9(10H)-anthracenones: inhibition of 12(S)-HETE biosynthesis and HaCaT cell growth.
    Müller K; Breu K
    Arch Pharm (Weinheim); 1999 Jan; 332(1):31-5. PubMed ID: 10073141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes.
    Denis D; Riendeau D
    Eur J Pharmacol; 1999 Feb; 367(2-3):343-50. PubMed ID: 10079010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis.
    Kolasa T; Gunn DE; Bhatia P; Basha A; Craig RA; Stewart AO; Bouska JB; Harris RR; Hulkower KI; Malo PE; Bell RL; Carter GW; Brooks CD
    J Med Chem; 2000 Aug; 43(17):3322-34. PubMed ID: 10966751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of 5-lipoxygenase and biosynthesis of leukotriene B4 in human monomorphonuclear leukocytes.
    Claesson HE; Jakobsson PJ; Steinhilber D; Odlander B; Samuelsson B
    J Lipid Mediat; 1993; 6(1-3):15-22. PubMed ID: 8395238
    [No Abstract]   [Full Text] [Related]  

  • 15. Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors.
    Kolasa T; Gunn DE; Bhatia P; Woods KW; Gane T; Stewart AO; Bouska JB; Harris RR; Hulkower KI; Malo PE; Bell RL; Carter GW; Brooks CD
    J Med Chem; 2000 Feb; 43(4):690-705. PubMed ID: 10691695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukotriene B4 mediates p47phox phosphorylation and membrane translocation in polyunsaturated fatty acid-stimulated neutrophils.
    Serezani CH; Aronoff DM; Jancar S; Peters-Golden M
    J Leukoc Biol; 2005 Oct; 78(4):976-84. PubMed ID: 16006535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depside as potent inhibitor of prostaglandin biosynthesis: a new active site model for fatty acid cyclooxygenase.
    Sankawa U; Shibuya M; Ebizuka Y; Noguchi H; Kinoshita T; Iitaka Y; Endo A; Kitahara N
    Prostaglandins; 1982 Jul; 24(1):21-34. PubMed ID: 6812170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arachidonic acid in postshock mesenteric lymph induces pulmonary synthesis of leukotriene B4.
    Jordan JR; Moore EE; Sarin EL; Damle SS; Kashuk SB; Silliman CC; Banerjee A
    J Appl Physiol (1985); 2008 Apr; 104(4):1161-6. PubMed ID: 18276905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
    Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic and structure/activity studies on acid-substituted 2-arylphenols: discovery of 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]-propoxy]phenoxy]benzoic acid, a high-affinity leukotriene B4 receptor antagonist.
    Sawyer JS; Bach NJ; Baker SR; Baldwin RF; Borromeo PS; Cockerham SL; Fleisch JH; Floreancig P; Froelich LL; Jackson WT
    J Med Chem; 1995 Oct; 38(22):4411-32. PubMed ID: 7473568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.